Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Autolus Therapeutics (AUTL) Shares Outstanding (2017 - 2025)

Autolus Therapeutics (AUTL) has disclosed Shares Outstanding for 7 consecutive years, with $34425.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Shares Outstanding changed 0.0% year-over-year to $34425.0, compared with a TTM value of $34425.0 through Dec 2024, changed 0.0%, and an annual FY2024 reading of $34425.0, changed 0.0% over the prior year.
  • Shares Outstanding was $34425.0 for Q4 2024 at Autolus Therapeutics, roughly flat from $34425.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $90.9 million in Q4 2021 and bottomed at $34425.0 in Q4 2022.
  • Average Shares Outstanding over 5 years is $36.0 million, with a median of $34425.0 recorded in 2022.
  • The sharpest move saw Shares Outstanding tumbled 100.0% in 2021, then surged 3442400.0% in 2023.
  • Year by year, Shares Outstanding stood at $52.3 million in 2020, then crashed by 100.0% to $1.0 in 2021, then changed by 0.0% to $1.0 in 2022, then soared by 3442400.0% to $34425.0 in 2023, then changed by 0.0% to $34425.0 in 2024.
  • Business Quant data shows Shares Outstanding for AUTL at $34425.0 in Q4 2024, $34425.0 in Q4 2023, and $1.0 in Q4 2022.